13204
β-tri-Calcium phosphate
puriss. p.a., ≥98% β-phase basis (unsintered powder)
別名:
β-TCP, β-Tricalcium phosphate
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
実験式（ヒル表記法）:
Ca3O8P2
CAS番号:
分子量:
310.18
UNSPSC Code:
12352302
PubChem Substance ID:
EC Number:
231-840-8
NACRES:
NA.55
MDL number:
Assay:
≥98% β-phase basis (unsintered powder)
Form:
powder
製品名
β-tri-Calcium phosphate, puriss. p.a., ≥98% β-phase basis (unsintered powder)
SMILES string
[Ca+2].[Ca+2].[Ca+2].[P](=O)([O-])([O-])[O-].[P](=O)([O-])([O-])[O-]
InChI
1S/3Ca.2H3O4P/c;;;2*1-5(2,3)4/h;;;2*(H3,1,2,3,4)/q3*+2;;/p-6
InChI key
QORWJWZARLRLPR-UHFFFAOYSA-H
grade
puriss. p.a.
assay
≥98% β-phase basis (unsintered powder)
form
powder
impurities
≤250 mg/kg total sulfur (as SO4) (ICP)
≤50 mg/kg total heavy metals (as lead)
anion traces
chloride (Cl-): ≤100 mg/L
cation traces
As: ≤0.5 mg/kg
Ba: ≤10 mg/kg
Cd: ≤1 mg/kg
Co: ≤1 mg/kg
Cr: ≤5 mg/kg
Cu: ≤1 mg/kg
Hg: ≤0.5 mg/kg
Ni: ≤1 mg/kg
Pb: ≤5 mg/kg
Zn: ≤10 mg/kg
Quality Level
類似した製品をお探しですか？ 訪問 製品比較ガイド
関連するカテゴリー
Analysis Note
Phase Composition (by XRD analysis)
Low crystalinity Hydroxylapatite at unsintered condition.
A high crystalinity ß-Tricalcium phosphate after sintering at 1100C.
ß-TCP: >98% (by x-ray diffraction analysis)
other Ca-P phases as Hydroxylapatite, a-TCP and Pyrophosphate <2.0%
Low crystalinity Hydroxylapatite at unsintered condition.
A high crystalinity ß-Tricalcium phosphate after sintering at 1100C.
ß-TCP: >98% (by x-ray diffraction analysis)
other Ca-P phases as Hydroxylapatite, a-TCP and Pyrophosphate <2.0%
General description
β-tri-Calcium phosphate belongs to the category of calcium-phosphate based ceramics, which has been involved in the preparation of a new biosynthetic material possessing morphogenetic activity that is used as a bone implant.
保管分類
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
A new polyphosphate calcium material with morphogenetic activity
Muller.G.EW, et al.
Materials Letters, 148, 163-166 (2015)
Timo Brandenburger et al.
Shock (Augusta, Ga.), 42(3), 234-238 (2014-07-01)
Remote ischemic preconditioning (RIPC) is an easily applicable method for protecting the heart against a subsequent ischemia and reperfusion (I/R) injury. However, the exact molecular mechanisms underlying RIPC are unknown. We examined the involvement of microRNAs (miRNAs) and in particular
Krzysztof W Luczynski et al.
Journal of biomedical materials research. Part A, 101(1), 138-144 (2012-07-25)
This paper is concerned with reliable and physically sound elasticity determination of rapid-prototyped tissue engineering scaffolds made of poly-L-lactide (PLLA), with and without small portions of tricalcium phosphate (TCP) inclusions. At the level of overall scaffolds, that is, that of
A H Choi et al.
Journal of dental research, 92(10), 853-859 (2013-07-17)
The purpose of coatings on implants is to achieve some or all of the improvements in biocompatibility, bioactivity, and increased protection from the release of harmful or unnecessary metal ions. During the last decade, there has been substantially increased interest
Floor C J van de Watering et al.
Journal of controlled release : official journal of the Controlled Release Society, 164(3), 283-290 (2012-07-18)
Clinical application of calcium phosphate cement (CPC; with incorporated polymeric porogens) in an injectable form implicates that loading methods for growth factors are limited. In view of this, the current study evaluated the in vitro and in vivo release kinetics
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）